Media Thread, page-14944

It is my understanding that if approval from FDA for
bile duct cancer occurs, then approval for other types
of cancer will be easier and quicker to obtain, which
will then give the shareprice a really strong push.
I noted that Paul said he and Lesley are in the US
every six weeks and I do feel that they are making
every effort to get the right people engaged and invested
in Imugene. Mark Bouris explored the "process" in more
depth than I have previously seen in an interview with
Imugene and anyone should see that this "process" is
long, hard and definitely risky. However Lesley seems
dedicated and determined so I have positive vibes.